A detailed history of Brevan Howard Capital Management LP transactions in Natera, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 9,436 shares of NTRA stock, worth $1.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,436
Holding current value
$1.53 Million
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $922,369 - $1.22 Million
9,436 New
9,436 $1.2 Million
Q1 2024

May 15, 2024

BUY
$59.21 - $92.9 $219,432 - $344,287
3,706 New
3,706 $338,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.